GenScript's founders recognized that limited access to high-quality and reliable reagents significantly restricted advances in life science research. Therefore, for over 20 years, GenScript has developed, adopted, and improved upon many innovative synthetic biology technologies, expanded its footprint, and established partnerships with scientists globally. Among these partnerships, GenScript's connection with the iGEM community is of particular significance. iGEM enables aspiring young scientists to imagine and collaborate in creating solutions for a brighter future with synthetic biology.